Zosano Pharma Corp

NASDAQ:ZSAN  
1.96
+0.05 (+2.62%)
Earnings Announcements, Equity Financing / Related

Zosano Pharma Q1 Loss Per Share $7.86

Published: 05/13/2022 20:13 GMT
Zosano Pharma Corp (ZSAN) - Zosano Pharma Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $7.86.
Will Need Substantial Additional Funding to Fund Its Operations.
Will Not Be Able to Continue As a Going Concern If It is Unable to Raise Additional Funds.
As of May 11, 2022, Company Had Approximately $9.9 Million of Cash and Cash Equivalents.
Zosano Pharma - All Share & per Share Information Included in Qtrly Results Retroactively Adjusted to Give Effect to 1-for-35 Reverse Stock Split.
Revenue is expected to be $0.1 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.